372 related articles for article (PubMed ID: 17516292)
1. Evaluation of biochemical hyperandrogenemia and body mass index in women presenting with amenorrhea.
Cupisti S; Dittrich R; Binder H; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 May; 115(5):298-302. PubMed ID: 17516292
[TBL] [Abstract][Full Text] [Related]
2. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
[TBL] [Abstract][Full Text] [Related]
3. Effects of ovarian drilling in middle Black Sea region Turkish women with polycystic ovary syndrome having normal and high body mass indices.
Demirturk F; Caliskan AC; Aytan H; Erkorkmaz U
J Obstet Gynaecol Res; 2006 Oct; 32(5):507-12. PubMed ID: 16984519
[TBL] [Abstract][Full Text] [Related]
4. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
[TBL] [Abstract][Full Text] [Related]
5. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.
Mueller A; Dittrich R; Cupisti S; Beckmann MW; Binder H
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):182-7. PubMed ID: 16705550
[TBL] [Abstract][Full Text] [Related]
6. Focus on BMI and subclinical hypothyroidism in adolescent girls first examined for amenorrhea or oligomenorrhea. The emerging role of polycystic ovary syndrome.
Nezi M; Christopoulos P; Paltoglou G; Gryparis A; Bakoulas V; Deligeoroglou E; Creatsas G; Mastorakos G
J Pediatr Endocrinol Metab; 2016 Jun; 29(6):693-702. PubMed ID: 27089404
[TBL] [Abstract][Full Text] [Related]
7. [Causes of menstrual disorders in adolescent girls--a retrospective study].
Bieniasz J; Zak T; Laskowska-Zietek A; Noczyńska A
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):205-10. PubMed ID: 17020657
[TBL] [Abstract][Full Text] [Related]
8. Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome.
Singh KB; Mahajan DK; Wortsman J
J Reprod Med; 1994 Oct; 39(10):805-8. PubMed ID: 7837128
[TBL] [Abstract][Full Text] [Related]
9. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
10. Prospective follow-up of menstrual disorders in adolescence and prognostic factors.
Wiksten-Almströmer M; Hirschberg AL; Hagenfeldt K
Acta Obstet Gynecol Scand; 2008; 87(11):1162-8. PubMed ID: 18956264
[TBL] [Abstract][Full Text] [Related]
11. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
12. Should androgen levels be measured in hirsute women with normal menstrual cycles?
Mehta A; Matwijiw I; Taylor PJ; Salamon EA; Kredentser JV; Faiman C
Int J Fertil; 1992; 37(6):354-7. PubMed ID: 1360456
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
14. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
Mesch VR; Siseles NO; Maidana PN; Boero LE; Sayegh F; Prada M; Royer M; Schreier L; Benencia HJ; Berg GA
Climacteric; 2008; 11(6):509-17. PubMed ID: 18991078
[TBL] [Abstract][Full Text] [Related]
15. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
16. Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
Vural B; Ozkan S; Bodur H
J Obstet Gynaecol Res; 2007 Apr; 33(2):166-73. PubMed ID: 17441890
[TBL] [Abstract][Full Text] [Related]
17. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
[TBL] [Abstract][Full Text] [Related]
18. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
19. [Correlations between clinical signs and hormonal parameters in young women with hirsutism].
Kristesashvili J; Chanukvadze D
Georgian Med News; 2011 Nov; 11(200):30-5. PubMed ID: 22201077
[TBL] [Abstract][Full Text] [Related]
20. The long-term effect of recombinant methionyl human leptin therapy on hyperandrogenism and menstrual function in female and pituitary function in male and female hypoleptinemic lipodystrophic patients.
Musso C; Cochran E; Javor E; Young J; Depaoli AM; Gorden P
Metabolism; 2005 Feb; 54(2):255-63. PubMed ID: 15690321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]